Anna Mowry - 19 Aug 2022 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
CFO and Treasurer
Signature
/s/ Matthew Murphy, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
19 Aug 2022
Net transactions value
+$40,218
Form type
4
Filing time
22 Aug 2022, 19:40:43 UTC
Previous filing
28 Jun 2022
Next filing
01 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $40,218 +17,500 +45% $2.30 56,750 19 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 17,500 shares purchased in the price range of $2.29 to $2.30 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.